- Investigator
- Jorge E Lascano
Clinical trials
-
Efficacy, Safety, and Tolerability of Brensocatib With Non-Cystic Fibrosis Bronchiectasis (ASPEN) -
STOP360-IP-22 The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of…
- Investigator
- Silvia Delgado
- Ages
- 6 Years - N/A
- Sexes
- All
-
VX21-522-001 The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to…
- Investigator
- Cesar A Trillo-Alvarez
- Ages
- 18 Years - 65 Years
- Sexes
- All
-
MAYFLOWERS In this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator…
- Investigator
- Cesar A Trillo-Alvarez
- Ages
- 16 Years - N/A
- Sexes
- Female